# Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.

> PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35230162-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-03-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35230162-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-35230162-bremelanotide-v1.json
- Content SHA-256: `4b129ab0bd4e9cce753c51399ac8c6234c8b355fe0b6533050f94eb5e2e30b80`

## Claims and source pins

### Headline

Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

### Summary

PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

### Paragraph 1

PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

## Sources

<a id="source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e"></a>
- **Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. · retained source version 1:2022-03-15:current:900a59f19c6ec3c2e62f436cec39fa89c6d909ecedce5887f501d4d6a698b301** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35230162/) (`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-35230162-bremelanotide-v1.json SHA-256: 4b129ab0bd4e9cce753c51399ac8c6234c8b355fe0b6533050f94eb5e2e30b80.